Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
06 February 2020Website:
http://www.schrodinger.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 21 Nov 2024 00:54:23 GMTDividend
Analysts recommendations
Institutional Ownership
SDGR Latest News
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.86 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR Symposium (ENA 2024). The data demonstrate that in preclinical models, treatment with SGR-3515 results in synergistic anti-tumor activity that leads to deeper and more durable responses compared to inhibitors that target only Wee1 or Myt1. The preclinical data also show that SGR-3515 has a favorable ph.
NEW YORK , Sept. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their fiduciary duties to shareholders.
Schrödinger, Inc. (NASDAQ:SDGR ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Communications Ramy Farid - President & Chief Executive Officer Geoff Porges - Chief Financial Officer Karen Akinsanya - President R&D, Therapeutics Conference Call Participants Michael Yee - Jefferies Scott Schoenhaus - KeyBanc Conor McKay - BMO Capital Markets David Leibowitz - Citi Matt Hewitt - Craig-Hallam Capital Chris Shibutani - Goldman Sachs Steven Mah - TD Cowen Operator Thank you for standing by. Welcome to Schrödinger's Conference Call to review our Second Quarter 2024 Financial Results.
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.21 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported that on June 11, 2024, the company granted (i) a non-statutory stock option and (ii) restricted stock units (RSUs).
Schrodinger, Inc. reported a quarterly loss of $0.76 per share, matching the Zacks Consensus Estimate. This is compared to a loss of $0.38 per share in the same quarter last year.
Schrödinger is set to announce its financial results for the first quarter of 2024 on May 1, 2024, after the close of the financial markets.
While the top- and bottom-line numbers for Schrodinger, Inc. (SDGR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.39 per share a year ago.
- 1(current)
What type of business is Schrödinger?
Schrodinger, Inc. is an American biotechnology company specializing in software for the discovery and research of new drugs. Founded in 1990, the company is headquartered in New York. Schrodinger has developed a computational platform that can predict critical properties of molecules with a high degree of accuracy. This key capability allows drug development teams to design and selectively synthesize molecules with more optimal properties, reducing on average the time and costs required to identify a development candidate, and increasing the likelihood that a drug discovery program will enter clinical development.
What sector is Schrödinger in?
Schrödinger is in the Healthcare sector
What industry is Schrödinger in?
Schrödinger is in the Health Information Services industry
What country is Schrödinger from?
Schrödinger is headquartered in United States
When did Schrödinger go public?
Schrödinger initial public offering (IPO) was on 06 February 2020
What is Schrödinger website?
https://www.schrodinger.com
Is Schrödinger in the S&P 500?
No, Schrödinger is not included in the S&P 500 index
Is Schrödinger in the NASDAQ 100?
No, Schrödinger is not included in the NASDAQ 100 index
Is Schrödinger in the Dow Jones?
No, Schrödinger is not included in the Dow Jones index
When was Schrödinger the previous earnings report?
No data
When does Schrödinger earnings report?
The next expected earnings date for Schrödinger is 28 February 2025